Correlation Between Dominari Holdings and Eliem Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and Eliem Therapeutics, you can compare the effects of market volatilities on Dominari Holdings and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and Eliem Therapeutics.

Diversification Opportunities for Dominari Holdings and Eliem Therapeutics

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dominari and Eliem is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and Eliem Therapeutics go up and down completely randomly.

Pair Corralation between Dominari Holdings and Eliem Therapeutics

Given the investment horizon of 90 days Dominari Holdings is expected to under-perform the Eliem Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dominari Holdings is 1.8 times less risky than Eliem Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Eliem Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  251.00  in Eliem Therapeutics on August 26, 2024 and sell it today you would earn a total of  49.00  from holding Eliem Therapeutics or generate 19.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Dominari Holdings  vs.  Eliem Therapeutics

 Performance 
       Timeline  
Dominari Holdings 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating primary indicators, Dominari Holdings may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Dominari Holdings and Eliem Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dominari Holdings and Eliem Therapeutics

The main advantage of trading using opposite Dominari Holdings and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.
The idea behind Dominari Holdings and Eliem Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance